Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
Clinical trial NCT05621759 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05621759
- Sponsor
- NYU Langone Health
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-07
- Primary completion
- 2027-01-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.